Acute Lymphoblastic Leukemia

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity 0 comments 0

Immune therapy induces remission for many with ALL

(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published ...

Oct 16, 2014
popularity 0 comments 0

Latest Spotlight News

The coming merge of human and machine intelligence

For most of the past two million years, the human brain has been growing steadily. But something has recently changed. In a surprising reversal, human brains have actually been shrinking for the last 20,000 ...